General Information of Drug Transporter (DT)
DT ID DTD0490 Transporter Info
Gene Name SLC9A6
Transporter Name Sodium/hydrogen exchanger 6
Gene ID
10479
UniProt ID
Q92581
Post-Translational Modification of This DT
Overview of SLC9A6 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A6 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

128

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC9A6 Asparagine 128 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A6 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

571

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC9A6 Cystine 571 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        13 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A6 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

166

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 166 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9A6 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

446

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 446 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC9A6 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

480

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 480 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC9A6 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

502

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 502 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC9A6 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

574

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 574 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC9A6 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

589

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 589 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC9A6 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

599

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 599 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC9A6 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

605

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 605 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC9A6 [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

614

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 614 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC9A6 [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

615

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 615 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC9A6 [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

624

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 624 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence SLC9A6 [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

625

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 625 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence SLC9A6 [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

654

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Serine 654 has the potential to affect its expression or activity.

  Threonine

        10 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A6 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

481

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 481 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9A6 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

482

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 482 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC9A6 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

489

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 489 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC9A6 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

497

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 497 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC9A6 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

498

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 498 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC9A6 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

573

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 573 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC9A6 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

601

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 601 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC9A6 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

606

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 606 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC9A6 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

609

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 609 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC9A6 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

613

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Threonine 613 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A6 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

602

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9A6 Tyrosine 602 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9A6 [16]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

443

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC9A6 Lysine 443 has the potential to affect its expression or activity.
References
1 Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61.
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4 Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
5 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
6 Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
7 Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
8 Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia. 2018 Jul;20(7):668-677.
9 MASTL overexpression promotes chromosome instability and metastasis in breast cancer. Oncogene. 2018 Aug;37(33):4518-4533.
10 Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
11 p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
12 Glycoprotein capture and quantitative phosphoproteomics indicate coordinated regulation of cell migration upon lysophosphatidic acid stimulation. Mol Cell Proteomics. 2010 Nov;9(11):2337-53.
13 Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
14 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
15 Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
16 Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry. Proteomics. 2007 Mar;7(6):868-74.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.